G. Papatheodoridis

发表

The comprehensive outcomes of hepatitis C virus infection: A multi‐faceted chronic disease

F. Negro, A. Hatzakis, L. Henry, 2018, Journal of viral hepatitis.

Assessment of dietary habits and the adequacy of dietary intake of patients with cirrhosis-the KIRRHOS study.

M. Kontogianni, M. Yannakoulia, P. Tsibouris, 2021, Clinical nutrition.

Association of antiviral therapy with reduced disease progression in chronic Hepatitis B patients: Results from a nation-wide cohort study.

G. Touloumi, G. Kitis, G. Dalekos, 2016, Hippokratia.

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

S. Pol, D. Nelson, M. Persico, 2017, The New England journal of medicine.

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.

V. Wong, V. de Lédinghen, M. Stepanova, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Letter: renal tubular dysfunction during nucleotide analogue therapy in chronic hepatitis B

S. Manolakopoulos, G. Papatheodoridis, G. Papatheodoridis, 2012, Alimentary pharmacology & therapeutics.

A Proposed Etiology for an Aberrant Response to Enteric Adenovirus Infection in Previously SARS-CoV-2-Infected Children With Acute Hepatitis

P. Sfikakis, S. Tsiodras, D. Paraskevis, 2022, Journal of the Pediatric Infectious Diseases Society.

Real-life cost of managing chronic HCV infection in Greece prior to Direct-Acting Antivirals (DAAs): an undeniable truth of spending more for less.

A. Hatzakis, K. Souliotis, S. Siakavellas, 2018, Hippokratia.

Acute and Late Rectal Toxicity Following Hypofractionated Radiotherapy in Patients With Prostate Cancer: Results of a Prospective Study

G. Kounadis, N. Syrigos, D. Grapsa, 2022, In Vivo.

A multinational Delphi consensus to end the COVID-19 public health threat

Manfred S. Green, Bary S. R. Pradelski, LeAnne K. Robinson, 2022, Nature.

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

R. Malekzadeh, F. Tacke, G. Marchesini, 2021, Journal of hepatology.

Diagnosis and management of pre‐core mutant chronic hepatitis B

S. Hadziyannis, G. Papatheodoridis, G. Papatheodoridis, 2001, Journal of viral hepatitis.

The usefulness of transient elastography in the assessment of patients with HBeAg‐negative chronic hepatitis B virus infection

D. Pectasides, G. Kafiri, M. Deutsch, 2014, Journal of viral hepatitis.

Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg‐negative chronic hepatitis B virus infection

E. Cholongitas, E. Hadziyannis, G. Papatheodoridis, 2008, Journal of viral hepatitis.

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

T. Asselah, P. Marcellin, D. Ouzan, 2020, PloS one.

PREDICTION OF SUSTAINED RESPONSE AFTER NUCLEO(S)TIDE ANALOGUE CESSATION USING HBSAG AND HBCRAG LEVELS - A MULTICENTER STUDY (CREATE).

M. Buti, T. Berg, F. Zoulim, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.

M. Buti, T. Berg, F. Zoulim, 2022, Journal of hepatology.

Serum HBsAg kinetics and usefulness of interferon‐inducible protein 10 serum in HBeAg‐negative chronic hepatitis B patients treated with tenofovir disoproxil fumarate

A. Georgiou, C. Triantos, E. Hadziyannis, 2015, Journal of viral hepatitis.

Future trends of HCV‐related cirrhosis and hepatocellular carcinoma under the currently available treatments

A. Hatzakis, G. Touloumi, V. Sypsa, 2005 .

Evaluation of the effectiveness of eight screening tools in detecting risk of malnutrition in cirrhotic patients: the KIRRHOS study

M. Kontogianni, M. Yannakoulia, P. Tsibouris, 2019, British Journal of Nutrition.

COVID-19 pandemic and worldwide organ transplantation: a population-based study

C. Jacquelinet, V. Sallinen, Dina Zielinski, 2021, The Lancet Public Health.

Effectiveness of Peginterferon Alfa-2a Therapy in HBeAg-Positive and HBeAg-Negative Patients with Chronic Hepatitis B: Final Results 3 Years Post-Treatment of the Prospective, Global, Observational S-Collate Study

T. Asselah, P. Marcellin, D. Ouzan, 2016 .

O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)

M. Buti, P. Marcellin, R. Idilman, 2015 .

Validation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS study

M. Kontogianni, M. Yannakoulia, M. Deutsch, 2019, Annals of gastroenterology.

Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.

P. Bossuyt, M. Allison, J. Dufour, 2023, The lancet. Gastroenterology & hepatology.

Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon‐alpha and ribavirin

D. Pectasides, M. Deutsch, S. Manolakopoulos, 2014, Journal of viral hepatitis.

Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™

M. Buti, S. Hamid, M. Stepanova, 2023, Journal of viral hepatitis.

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence

D. Nelson, J. Dillon, A. Luetkemeyer, 2021, The American journal of gastroenterology.

Severe impairment of patient‐reported outcomes in patients with chronic hepatitis C virus infection seen in real‐world practices across the world: Data from the global liver registry

M. Buti, S. Hamid, M. Stepanova, 2022, Journal of viral hepatitis.

The Inflammatory Bowel Disease—Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version

I. Papaconstantinou, K. Katsanos, D. Christodoulou, 2023, Journal of Clinical Medicine.

Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe

J. Lazarus, E. Cholongitas, P. van Damme, 2018, Journal of viral hepatitis.

The First External Validation of the Dallas Steatosis Index in Biopsy-proven Non-alcoholic Fatty Liver Disease: a Multicenter study.

C. Mantzoros, G. Markakis, G. Mingrone, 2023, Diabetes research and clinical practice.

Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive non-alcoholic fatty liver disease indexes: Results from a large multi-center study.

C. Mantzoros, G. Markakis, S. Polyzos, 2023, Metabolism: clinical and experimental.

Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis.

M. Eslam, Pavlina Chrysafi, A. Katsarou, 2023, Metabolism: clinical and experimental.

High levels of all-cause mortality among people who inject drugs from 2018 to 2022.

D. Paraskevis, I. Goulis, V. Sypsa, 2024, The International journal on drug policy.

Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study

P. Bossuyt, M. Allison, J. Dufour, 2023, Hepatology.